INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Operating Profit History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr | ₹3.96 Cr | ₹3.42 Cr |
What is the latest Operating Profit of INDO US BIOTECH ?
Year | Operating Profit |
---|---|
Mar2024 | ₹9.39 Cr |
Mar2023 | ₹6.93 Cr |
Mar2022 | ₹5.51 Cr |
Mar2021 | ₹3.96 Cr |
Mar2020 | ₹3.42 Cr |
How is Operating Profit of INDO US BIOTECH Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹9.39 Cr | 35.52 | |
Mar2023 | ₹6.93 Cr | 25.70 | |
Mar2022 | ₹5.51 Cr | 39.10 | |
Mar2021 | ₹3.96 Cr | 15.91 | |
Mar2020 | ₹3.42 Cr | - |
Compare Operating Profit of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹351.0 Cr | 3.1% | 13.1% | -25.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,852.0 Cr | -3.9% | -6.6% | -13.6% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,627.2 Cr | -3.2% | -6.3% | -1.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,113.2 Cr | -0.4% | -6.5% | -21.8% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,413.9 Cr | -4.1% | -5.7% | -31.2% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹537.5 Cr | -7% | 5.4% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 3.1% |
13.1% |
-25.7% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses